Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Submit your nominations for the Fierce CRO Awards
Galapagos
Biotech
Adaptimmune questions own longevity, axes preclinical funding
Adaptimmune is cutting enrollment for clinical programs and evaluating strategic options in efforts to save cash.
Gabrielle Masson
Mar 20, 2025 2:04pm
Galapagos drops one CD19 CAR-T to focus on 'flagship' program
Feb 13, 2025 8:00am
Galapagos splits in 2, laying off 40% of staff
Jan 8, 2025 4:49am
Galapagos’ stock up as fund shows intent to shape its evolution
Aug 26, 2024 8:45am
Galapagos pauses CAR-T cell therapy trial over Parkinsonism case
Aug 2, 2024 8:49am
Galapagos selects Adaptimmune cell therapy in $665M collab
May 31, 2024 9:40am
